These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
63 related articles for article (PubMed ID: 8285366)
1. [Blood groups as a risk factor in venous thrombosis]. Hernández Cañete CM; Alvarez Dieguez R; González Sánchez M de la C; Díaz Hernández C; Sánchez Montiel ME Angiologia; 1993; 45(5):180-3. PubMed ID: 8285366 [TBL] [Abstract][Full Text] [Related]
2. [Venous thrombosis of the legs and cancer. Evaluation of risk factors of venous thrombosis in the medical environment]. Giauffret F; Pottier P; Pistorius MA; Planchon B J Mal Vasc; 1997 Oct; 22(4):234-8. PubMed ID: 9411008 [TBL] [Abstract][Full Text] [Related]
3. Rheology of the post-thrombotic syndrome. Ernst E J Mal Vasc; 1992; 17 Suppl B():93-6. PubMed ID: 1602255 [TBL] [Abstract][Full Text] [Related]
4. Factor V Leiden and thrombotic complications in heparin-induced thrombocytopenia. Lee DH; Warkentin TE; Denomme GA; Lagrotteria DD; Kelton JG Thromb Haemost; 1998 Jan; 79(1):50-3. PubMed ID: 9459322 [TBL] [Abstract][Full Text] [Related]
5. [Sequelae of venous thrombosis. Incidence in of the post-thrombosis syndrome after 5 years]. Barras JP; Widmer MT; Zemp E; Voilin R; Widmer LK J Mal Vasc; 1991; 16(2):115-8. PubMed ID: 1861102 [TBL] [Abstract][Full Text] [Related]
6. [Thrombolytic treatment of venous thrombosis]. Straub H Verh Dtsch Ges Inn Med; 1990; 96():343-54. PubMed ID: 2092452 [No Abstract] [Full Text] [Related]
8. Effectiveness of mesoglycan in patients with previous deep venous thrombosis and chronic venous insufficiency. Andreozzi GM Minerva Cardioangiol; 2007 Dec; 55(6):741-53. PubMed ID: 18091643 [TBL] [Abstract][Full Text] [Related]
9. Thrombosis in the young: epidemiology and risk factors. A focus on venous thrombosis. Rosendaal FR Thromb Haemost; 1997 Jul; 78(1):1-6. PubMed ID: 9198119 [TBL] [Abstract][Full Text] [Related]
10. The mutation Ala677-->Val in the methylene tetrahydrofolate reductase gene: a risk factor for arterial disease and venous thrombosis. Arruda VR; von Zuben PM; Chiaparini LC; Annichino-Bizzacchi JM; Costa FF Thromb Haemost; 1997 May; 77(5):818-21. PubMed ID: 9184384 [TBL] [Abstract][Full Text] [Related]
11. The 20210 A allele of the prothrombin gene is a common risk factor among Swedish outpatients with verified deep venous thrombosis. Hillarp A; Zöller B; Svensson PJ; Dahlbäck B Thromb Haemost; 1997 Sep; 78(3):990-2. PubMed ID: 9308741 [TBL] [Abstract][Full Text] [Related]
12. Familial elevated factor VIII in children with symptomatic venous thrombosis and post-thrombotic syndrome: results of a multicenter study. Kreuz W; Stoll M; Junker R; Heinecke A; Schobess R; Kurnik K; Kelsch R; Nowak-Göttl U Arterioscler Thromb Vasc Biol; 2006 Aug; 26(8):1901-6. PubMed ID: 16709943 [TBL] [Abstract][Full Text] [Related]
13. Postphlebitic syndrome after total knee arthroplasty: 405 patients examined 2-10 years after surgery. Deehan DJ; Siddique M; Weir DJ; Pinder IM; Lingard EM Acta Orthop Scand; 2001 Feb; 72(1):42-5. PubMed ID: 11327412 [TBL] [Abstract][Full Text] [Related]
14. [Venous thromboembolic pathology. New acquired risk factors or new data on acquired risk factors]. Drouet L Arch Mal Coeur Vaiss; 2001 Nov; 94(11 Suppl):1318-26. PubMed ID: 11794976 [TBL] [Abstract][Full Text] [Related]
15. Relationship between deep venous thrombosis and the postthrombotic syndrome. Kahn SR; Ginsberg JS Arch Intern Med; 2004 Jan; 164(1):17-26. PubMed ID: 14718318 [TBL] [Abstract][Full Text] [Related]
16. Free protein S deficiency is a risk factor for venous thrombosis. Faioni EM; Valsecchi C; Palla A; Taioli E; Razzari C; Mannucci PM Thromb Haemost; 1997 Nov; 78(5):1343-6. PubMed ID: 9408016 [TBL] [Abstract][Full Text] [Related]
17. Value of venous pressure and phlebography in detecting deep vein thrombosis after major surgery and in primary venous disease. Kesarwani RC; Mittal S J Indian Med Assoc; 1993 Feb; 91(2):33-5. PubMed ID: 8501309 [TBL] [Abstract][Full Text] [Related]
18. The post-thrombotic syndrome: progress and pitfalls. Kahn SR Br J Haematol; 2006 Aug; 134(4):357-65. PubMed ID: 16822286 [TBL] [Abstract][Full Text] [Related]
19. A multicenter randomized double-blind study of enoxaparin compared with unfractionated heparin in the prevention of venous thromboembolic disease in elderly in-patients bedridden for an acute medical illness. The Enoxaparin in Medicine Study Group. Bergmann JF; Neuhart E Thromb Haemost; 1996 Oct; 76(4):529-34. PubMed ID: 8902991 [TBL] [Abstract][Full Text] [Related]
20. Protein Z levels and anti-protein Z antibodies in patients with arterial and venous thrombosis. Pardos-Gea J; Ordi-Ros J; Serrano S; Balada E; Nicolau I; Vilardell M Thromb Res; 2008; 121(6):727-34. PubMed ID: 17869328 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]